OHSU Knight Cancer Institute

OHSU Knight Cancer Network Symposium

A banner that reads "Save the Date" and "7th Annual OHSU Knight Cancer Network Symposium Friday, March 3, 2023 7:30a.m. - 3:15p.m." at the "Knight Cancer Research Building, 1st Floor Auditorium."

About the symposium

Learn about recent advances in cancer care, research and programs at OHSU and across the Knight Cancer Network in an engaging and interactive environment at this annual symposium. Join us in person at the Knight Cancer Research Building in Portland or via Webex.

Who should attend

This event is designed for cancer care teams and staff associated with the OHSU Knight Cancer Network. This includes but is not limited to medical oncologists, hematologists, radiation oncologists, surgeons, advance practice providers, researchers, administrators, clinical leaders, and staff.

Continuing Medical Education (CME)

Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

OHSU School of Medicine designates this live activity for a maximum 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact us

For questions about this event, please email our team at cancernetwork@ohsu.edu .

Join us at this annual event

People talking at a conference

Friday, March 3
7:30 a.m. - 3:15 p.m.
Knight Cancer Research Building | Webex

Event archive

Click the links below to view presentations from the 2021 Knight Cancer Network Symposium in PDF format:

Knight Cancer Institute Highlights and Vision for the Future
Shivaani Kummar, M.D., F.A.C.P.

Understanding Interval Breast Cancers that are Missed by Mammogram Screening
Zhenzhen Zhang, Ph.D., M.P.H., M.Med

OHSU: Comprehensive Center of Excellence in Lymphatic Disease
Allison Nauta, M.D.

Radiotherapeutic Management of the Axilla in Breast Cancer
Kiri Cook, M.D.

Process Improvement: Assessing Your Risk and Tools for Taking Action
Bailey Buckingham
Caitlin Kapper

Adjunctive Hepatic Arterial Infusion to Convert Patients with Unresectable Liver Cancer to a Resectable Status
Skye Mayo, M.D., M.P.H., F.A.C.S.

GI Oncology- Meet the Experts and Q&A
Adel Kardosh, M.D., Ph.D.

The Cancer Committee Meeting – How to Create a High Quality, Dynamic Forum
V Liana Tsikitis, M.D., M.B.A., M.C.R.
Melissa Alvarado, M.P.H., C.T.R.

Brachytherapy for Prostate and Gynecologic Cancers: Moving the Needle
Jenna Kahn, M.D

OHSU Pancreatic Cancer Early Detection Surveillance Clinic and the PRECEDE Study
Brett Sheppard, M.D.
Aaron Grossberg, M.D., Ph.D.

Advocacy and Quality Improvement in Pancreatobiliary Cancer
Flavio Rocha, M.D.